Yongquan Wang et al. found low RGS12 protein expression in prostate cancer tissues and cells obtained from African-Americans and demonstrated that RGS12, as a novel tumour suppressor, can inhibit the AKT and MNX1 signalling pathways [109]. Here, RGS12 is linked to prostate carcinoma.